RNA interference mediated knockdown of target genes in clinical research and therapy of breast cancer
(0) Breast cancer is the second leading cause of cancer deaths and the major cancer in females in industrialized countries. Currently breast cancer therapy is still traditional surgery and adjunct with chemotherapy, radiotherapy and hormone therapy. All have side effects and limitations for normal cells. Moreover, they do not guarantee a complete eradication of tumor cells from the body and a prolonged lifespan. So far, multiple molecular abnormalities regulated by genes, which play critical roles in tumor progression and resistance to existing chemoradiational therapy, have been identified in breast cancer.
Lin Hong Tang Xiao-Jun Zhu Jin Guan Xiao-Hong
Key Laboratory of Antibody Technique of Health Ministry, Nanjing Medical University, Nanjing, 210029 Huadong Medical Institute of Biotechniques, Nanjing, 210002, China
国际会议
International Symposium on Medical and Pharmaceutical Biotechnology(医药生物技术国际研讨会)
南京
英文
146-149
2009-04-27（万方平台首次上网日期，不代表论文的发表时间）